Session date: 
01/28/2019 - 7:30am to 8:15am

Presenters:    
Robert D. McBane, II, M.D.
Charles (Charlie) J. Lenz, M.D.


Learning Objectives:

  1. Review the role of direct oral anticoagulants in the treatment of patients with antiphospholipid antibody syndrome
  2. Identify the risk and clinical manifestations of valve thrombosis and destruction in patients with antiphospholipid antibody syndrome
  3. Review the ramifications of catastrophic antiphospholipid antibody syndrome and new paradigms for treatment


For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota